Although FSHR gene expression has been described as functional in other extragonadal cells [31–33], our findings show that we currently have no indication that FSH stimulation on the FSHR has a direct effect on the enhanced AAA development in women during the menopausal transition. The gene discussed is BRD2; the disease is triple-A syndrome.